Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction.

Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ.

Circ Cardiovasc Interv. 2012 Apr;5(2):270-8. doi: 10.1161/CIRCINTERVENTIONS.111.966226. Epub 2012 Apr 10.

PMID:
22496085
[PubMed - indexed for MEDLINE]
Free Article
2.

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.

Lønborg J, Kelbæk H, Vejlstrup N, Bøtker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Terkelsen CJ, Schoos MM, Køber L, Clemmensen P, Treiman M, Engstrøm T.

Circ Cardiovasc Interv. 2012 Apr;5(2):288-95. doi: 10.1161/CIRCINTERVENTIONS.112.968388. Epub 2012 Apr 10.

PMID:
22496084
[PubMed - indexed for MEDLINE]
Free Article
3.

Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators, Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P.

Circulation. 2008 Feb 19;117(7):886-96. doi: 10.1161/CIRCULATIONAHA.107.759167. Epub 2008 Feb 4.

PMID:
18250271
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.

Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E, Venugopal V, Walker M, Holdright D, Swanton H, Crake T, Brull D, Moon JC, Puranik R, Muthurangu V, Taylor A, Hausenloy DJ.

Heart. 2011 Oct;97(19):1560-5. doi: 10.1136/hrt.2011.223867. Erratum in: Heart. 2011 Nov;97(21):1812. Mutharangu, Vivek [corrected to Muthurangu, Vivek].

PMID:
21900585
[PubMed - indexed for MEDLINE]
5.

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.

Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochman JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PW; COMMA Investigators.

Circulation. 2003 Sep 9;108(10):1184-90. Epub 2003 Aug 18.

PMID:
12925454
[PubMed - indexed for MEDLINE]
Free Article
6.

Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.

Lønborg J, Kelbaek H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrøm T.

Circ Cardiovasc Interv. 2010 Feb 1;3(1):34-41. doi: 10.1161/CIRCINTERVENTIONS.109.905521. Epub 2010 Jan 26.

PMID:
20118154
[PubMed - indexed for MEDLINE]
Free Article
7.

Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.

Pizzetti G, Mailhac A, Li Volsi L, Di Marco F, Lu C, Margonato A, Chierchia SL.

Ital Heart J. 2001 Oct;2(10):757-65.

PMID:
11721720
[PubMed - indexed for MEDLINE]
8.

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.

Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW; COMPLY Investigators.

Circulation. 2003 Sep 9;108(10):1176-83. Epub 2003 Aug 18.

PMID:
12925455
[PubMed - indexed for MEDLINE]
Free Article
9.

A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.

Kopecky SL, Aviles RJ, Bell MR, Lobl JK, Tipping D, Frommell G, Ramsey K, Holland AE, Midei M, Jain A, Kellett M, Gibbons RJ; AmP579 Delivery for Myocardial Infarction REduction study.

Am Heart J. 2003 Jul;146(1):146-52.

PMID:
12851624
[PubMed - indexed for MEDLINE]
10.

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Süselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT; F.I.R.E. Investigators.

J Am Coll Cardiol. 2009 Feb 24;53(8):720-9. doi: 10.1016/j.jacc.2008.12.017.

PMID:
19232907
[PubMed - indexed for MEDLINE]
Free Article
11.

Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.

Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB; CARDINAL investigators.

Coron Artery Dis. 2012 Mar;23(2):118-25. doi: 10.1097/MCA.0b013e32834e4f8f.

PMID:
22217457
[PubMed - indexed for MEDLINE]
12.

Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.

Stone GW, Martin JL, de Boer MJ, Margheri M, Bramucci E, Blankenship JC, Metzger DC, Gibbons RJ, Lindsay BS, Weiner BH, Lansky AJ, Krucoff MW, Fahy M, Boscardin WJ; AMIHOT-II Trial Investigators.

Circ Cardiovasc Interv. 2009 Oct;2(5):366-75. doi: 10.1161/CIRCINTERVENTIONS.108.840066. Epub 2009 Sep 15.

PMID:
20031745
[PubMed - indexed for MEDLINE]
Free Article
13.

Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.

Agati L, Voci P, Hickle P, Vizza DC, Autore C, Fedele F, Feinstein SB, Dagianti A.

J Am Coll Cardiol. 1998 Feb;31(2):338-43.

PMID:
9462577
[PubMed - indexed for MEDLINE]
Free Article
14.

Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.

Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ.

JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12. Erratum in: JACC Cardiovasc Imaging. 2010 Jul;3(7):796. Velleti, Uma S [corrected to Valeti, Uma S].

PMID:
20129531
[PubMed - indexed for MEDLINE]
Free Article
15.

Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.

Sörensson P, Saleh N, Bouvier F, Böhm F, Settergren M, Caidahl K, Tornvall P, Arheden H, Rydén L, Pernow J.

Heart. 2010 Nov;96(21):1710-5. doi: 10.1136/hrt.2010.199430.

PMID:
20956486
[PubMed - indexed for MEDLINE]
16.

Effect of cyclosporine on reperfusion injury in acute myocardial infarction.

Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M.

N Engl J Med. 2008 Jul 31;359(5):473-81. doi: 10.1056/NEJMoa071142.

PMID:
18669426
[PubMed - indexed for MEDLINE]
Free Article
18.

Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.

Nijveldt R, van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JG, Piek JJ, van Rossum AC, Zijlstra F.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1187-94. doi: 10.1016/j.jcmg.2009.06.008.

PMID:
19833308
[PubMed - indexed for MEDLINE]
Free Article
19.

ST-segment elevation during dobutamine stress testing predicts functional recovery after acute myocardial infarction.

Piérard LA, Lancellotti P, Kulbertus HE.

Am Heart J. 1999 Mar;137(3):500-11.

PMID:
10047633
[PubMed - indexed for MEDLINE]
20.

Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Appelbaum E, Abraham JM, Pride YB, Harrigan CJ, Peters DC, Biller LH, Manning WJ, Gibson CM.

Am Heart J. 2009 Jul;158(1):84-91. doi: 10.1016/j.ahj.2009.04.012.

PMID:
19540396
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk